OraQuick HIV Self Test

Composition:

The OraQuick HIV test consists of the following components:

1. **Test Device**: A test strip or device that contains:

• **Antibodies**: Specific antibodies that bind to HIV-1 and HIV-2 antibodies present in the sample.
• **Control Line**: A line that indicates the test has been performed correctly.
• **Sample Pad**: Where the oral fluid or blood sample is applied.

2. **Buffer Solution**: A solution that helps to facilitate the reaction between the sample and the antibodies on the test device.

3. **Instructions for Use**: Detailed guidelines on how to perform the test, interpret results, and handle samples.

 Indications:

The OraQuick HIV test is indicated for:

• Men who have sex with men (MSM)
• Individuals with multiple sexual partners
• People who inject drugs
• Individuals with a history of sexually transmitted infections (STIs)

1. **HIV Screening**: It is used for the preliminary screening of individuals for HIV infection, particularly in settings where rapid results are needed.
2. **High-Risk Populations**: Recommended for individuals at higher risk of HIV exposure, including:
3. **Follow-Up Testing**: Positive results from the OraQuick test should be confirmed with a laboratory-based test for definitive diagnosis.
4. **Public Health Initiatives**: Used in community outreach programs, testing events, and other public health initiatives aimed at increasing awareness and testing for HIV.

### Important Notes:

• The OraQuick test is not a substitute for clinical diagnosis or treatment.
• A negative result does not rule out HIV infection, especially if exposure occurred within the last 3 months.
• Individuals should be counseled on the importance of follow-up testing and safe practices.

Always refer to the specific product insert and guidelines provided by the manufacturer for detailed information and instructions.